Incyte (INCY, $68.6) was one of top quarterly gainers, jumping +3 to $68.6 per share. A.I.dvisor analyzed 873 stocks in the Biotechnology Industry over the last three months, and discovered that of them (6) charted an Uptrend while of them (3) trended down.